pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
ARVINAS, INC. ($ARVN) · catalysts · pharmadog
← back to ARVINAS, INC.
Catalysts for $ARVN
3
tracked
Nov 4, 2026
earnings
in 3mo
ARVINAS, INC. earnings
ARVINAS, INC.
→
Apr 30, 2026
earnings
4mo ago
ARVINAS, INC. earnings
ARVINAS, INC.
→
Apr 30, 2026
phase 1 2 completion
4mo ago
Arvinas Inc — samuraciclib (Phase I/II Trial Completion)
samuraciclib
→
$ARVN
9.0250
-6.77%
$ARVN
9.0250
-6.77%
$ARVN
9.0250
-6.77%
